Related Experiment Video
Updated: Jun 23, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess
Eileen E Reynolds1, Amy Weinstein2, Huma Farid3
1Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.E.R., H.L.).
Cervical cancer screening guidelines differ by age, with new recommendations for human papillomavirus (HPV) testing. Experts debate applying these to a 22-year-old unvaccinated woman with no prior screening history.
Area of Science:
- Oncology
- Preventive Medicine
- Public Health
Background:
- Cervical cytology screening has significantly decreased cervical cancer rates in the U.S.
- Human papillomavirus (HPV) immunization is expected to further reduce incidence.
- Conflicting guidelines exist regarding the optimal age and method for cervical cancer screening initiation.
Purpose of the Study:
- To debate the application of current cervical cancer screening guidelines to a specific patient case.
- To analyze the differences between American Cancer Society and U.S. Preventive Services Task Force recommendations.
- To discuss the role of HPV testing versus cytology in primary screening.
Main Methods:
- Expert debate format.
- Case study presentation of a 22-year-old woman with no prior cervical cancer screening.
- Analysis of current clinical guidelines from major health organizations.
Main Results:
- The American Cancer Society recommends starting screening at age 25 with HPV testing.
- The U.S. Preventive Services Task Force recommends starting screening at age 21 with cytology.
- The case highlights the complexities in applying differing guidelines to young women.
Conclusions:
- There is ongoing debate regarding the optimal age and method for initiating cervical cancer screening.
- The increasing uptake of HPV vaccination influences screening strategies.
- Individualized patient factors and guideline interpretation are crucial for clinical decision-making.
Related Concept Videos
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Preventive Healthcare Services
Cancer Prevention
Some...
Nursing Assessment of the Genitourinary System I: Health History

